ARS Investment Partners’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$3K 178
2022
Q1
$3K Hold
10,000
﹤0.01% 172
2021
Q4
$4K Hold
10,000
﹤0.01% 177
2021
Q3
$7K Buy
+10,000
New +$10.7K ﹤0.01% 167

Other funds holding ATIP.WS

ARS Investment Partners's ATIP.WS Position: Q2 2022 in Review

ARS Investment Partners sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q2 2022, closing a stake of 10,000 shares — an estimated $3K sold.

ARS Investment Partners first reported a position in ATIP.WS in Q3 2021 and held it in 3 quarters. The position peaked at $7K in Q3 2021. 18 funds tracked by Wall St. Rank hold ATIP.WS as of Q2 2022.

  • ARS Investment Partners reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • ARS Investment Partners sold 10,000 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $3K.
  • ARS Investment Partners first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q3 2021 and held it in 3 quarters.
  • ARS Investment Partners's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $7K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2022.

Based on ARS Investment Partners's 13F filing for Q2 2022, filed 15 Jul 2022.